Publication | Closed Access
A protein vaccine with Alum/c-GAMP/poly(I:C) rapidly boosts robust immunity against SARS-CoV-2 and variants of concern
18
Citations
26
References
2022
Year
VaccinationTernary Adjuvant SystemVaccine DevelopmentVaccine ResearchProtein VaccineVaccine TargetImmunologyRobust ImmunityVirologyHumoral ImmunityT Cell ImmunityVaccine DesignMedicineTernary Adjuvant GroupViral ImmunityTernary Adjuvant VaccineCovid-19
Adjuvants are important components in vaccines to increase the immunogenicity of proteins and induce optimal immunity. In this study, we designed a novel ternary adjuvant system Alum + c-GAMP + poly(I:C) with STING agonist 3,3'-c-GAMP (c-GAMP) and TLR3 agonist poly(I:C) co-adsorbed on the conventional adjuvant aluminum gel (Alum), and further constructed an S1 protein vaccine. Two doses of vaccination with the ternary adjuvant vaccine were sufficient to induce a balanced Th1/Th2 immune response and robust humoral and cellular immunity. Additionally, the ternary adjuvant group had effective neutralizing activity against live virus SARS-CoV-2 and pseudovirus of all variants of concern (alpha, beta, gamma, delta and omicron). These results indicate that the ternary adjuvants have a significant synergistic effect and can rapidly trigger potent immune responses; the combination of the ternary adjuvant system with S1 protein is a promising COVID-19 vaccine candidate.
| Year | Citations | |
|---|---|---|
Page 1
Page 1